Abstract
Transgender and gender diverse (TGD) youth receiving pubertal suppression treatment may be at risk for future infertility if they progress on to gender-affirming hormones. Little is known about whether and how parents of TGD youth consider fertility-related implications when making medical decisions about pubertal suppression treatment. We conducted interviews with 13 parents of 11 TGD youth about fertility-related considerations in the context of treatment decision-making. Three major themes were identified: (1) current fertility knowledge and counseling experiences, (2) barriers to parent–child discussions around fertility, and (3) importance of fertility in treatment decision-making. Findings highlight the complex nature of fertility considerations in this population.
Acknowledgements
We thank all the participants for their thoughtful contributions in the interviews. We also thank Robert Garofalo, MD, MPH for his leadership within the Gender & Sex Development Program that made this research possible; Teresa K. Woodruff, PhD, for her ongoing support of our work to expand Oncofertility to other patient populations at risk for infertility; Marco Hidalgo, PhD, Jennifer Jensen, APRN, Ellie Kim, MD, Ginny Scheffler, RN, Lisa Simons, MD, and D. Javier Thompson, LCSW for assistance recruiting study participants; and Ilina Rosoklija, MPH and Anthony D’Oro, BA for feedback on our interview guide.
Disclosure statement
The authors report there are no competing interests to declare.